ISoP is pleased to announce Vijay Ivaturi, Ph.D., as the 2023 President-Elect. Dr. Ivaturi will serve in this role for a one-year term and then will assume the ISoP presidency in January 2024, for a two-year term. As President-Elect, Dr. Ivaturi will oversee the development of ISoP’s three-year strategic plan to advance ISoP’s mission for the promotion and advancement of the discipline…
We are excited to spotlight Dr. Stephen Greene and his model-informed development of mRNA vaccines and therapeutics across multiple therapeutic areas including infectious diseases, oncology, and rare diseases. Learn about Dr. Greene’s work here.
The Annual Scientific Event For Professionals Dedicated To Furthering The Disciplines In Pharmacometrics Now is the time to register for the 13th American Conference on Pharmacometrics (ACoP13), the Annual Scientific Meeting of the International Society of Pharmacometrics (ISoP). The theme of ACoP13 is “Together Moving Mountains.” As we come back together after a challenging time,…
To promote the application of pharmacometrics to direct patient care, the International Society of Pharmacometrics (ISOP) and the American College of Clinical Pharmacology are dedicated to fostering an international Special Interest Group of scientists and clinicians who span a wide scope of therapeutic specialties.
The MCS SIG is a forum for ISoP members sharing common interests in advancing mathematical and computational
Welcome to the home of ISoP’s new Special Interest Group (SIG) on Quantitative Systems Pharmocology. This SIG will be a forum for discussion and information sharing between members of ISoP with a interest in systems pharmocology.
The Statistics and Pharmacometrics Interest Group (SxP) was named in 2016 and is chartered by both the American Statistical Association (ASA) and International Society of Pharmacometrics (ISOP). This Interest Group promotes collaboration between Statisticians and Pharmacometricians
